Literature DB >> 11116059

Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice.

M Van Eck1, M P De Winther, N Herijgers, L M Havekes, M H Hofker, P H Groot, T J Van Berkel.   

Abstract

In the arterial wall, scavenger receptor class A (SRA) is implicated in pathological lipid deposition. In contrast, in the liver, SRA is suggested to remove modified lipoproteins from the circulation, thereby protecting the body from their pathological action. The role of SRA on bone marrow-derived cells in lipid metabolism and atherogenesis was assessed in vivo by transplantation of bone marrow cells overexpressing human SRA (MSR1) to apoE-deficient mice. In vitro studies with peritoneal macrophages from the transplanted mice showed that macrophage scavenger receptor function, as measured by cell association and degradation studies with acetylated LDL, was approximately 3-fold increased on overexpression of MSR1 in bone marrow-derived cells as compared with control mice. Despite the increased macrophage scavenger receptor function in vitro, no significant effect of MSR1 overexpression in bone marrow-derived cells on the in vivo atherosclerotic lesion development was found. In addition to arterial wall macrophages, liver sinusoidal Kupffer cells also overexpress MSR1 after bone marrow transplantation, which may scavenge atherogenic particles more efficiently from the blood compartment. Introduction of bone marrow cells overexpressing human MSR1 in apoE-deficient mice induced a significant reduction in serum cholesterol levels of approximately 20% (P:<0.001, 2-way ANOVA) as the result of a decrease in VLDL cholesterol. It is suggested that the reduction in VLDL cholesterol levels is due to increased clearance of modified lipoproteins by the overexpressed MSR1 in Kupffer cells of the liver, thereby protecting the arterial wall against the proatherogenic action of modified lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11116059     DOI: 10.1161/01.atv.20.12.2600

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  Targeting Innate Immunity for CV Benefit.

Authors:  Kathryn J Moore; Mason W Freeman
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 2.  Class A1 scavenger receptors in cardiovascular diseases.

Authors:  Jingjing Ben; Xudong Zhu; Hanwen Zhang; Qi Chen
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

3.  Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.

Authors:  Xinbing Han; Shiro Kitamoto; Hongwei Wang; William A Boisvert
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

4.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

5.  Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages.

Authors:  Xinbing Han; Shiro Kitamoto; Qingyu Lian; William A Boisvert
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

6.  Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.

Authors:  Fenghua Zhou; Yunyun Pan; Zhiyong Huang; Yuhua Jia; Xiaoshan Zhao; Yuyao Chen; Jianxin Diao; Qiang Wan; Xiaobing Cui
Journal:  Cell Stress Chaperones       Date:  2013-03-15       Impact factor: 3.667

7.  IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.

Authors:  Khatuna Gabunia; Stephen Ellison; Sheri Kelemen; Farah Kako; William D Cornwell; Thomas J Rogers; Prasun K Datta; Mireille Ouimet; Kathryn J Moore; Michael V Autieri
Journal:  Am J Pathol       Date:  2016-03-04       Impact factor: 4.307

8.  Chitinase inhibition promotes atherosclerosis in hyperlipidemic mice.

Authors:  Shiro Kitamoto; Kensuke Egashira; Toshihiro Ichiki; Xinbing Han; Sara McCurdy; Shohei Sakuda; Kenji Sunagawa; William A Boisvert
Journal:  Am J Pathol       Date:  2013-05-15       Impact factor: 4.307

9.  Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice.

Authors:  Xinmei Zhu; Hang Pong Ng; Yen-Chun Lai; Jodi K Craigo; Pruthvi S Nagilla; Pooja Raghani; Shanmugam Nagarajan
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

10.  Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries.

Authors:  Stefano Cagnin; Michele Biscuola; Cristina Patuzzo; Elisabetta Trabetti; Alessandra Pasquali; Paolo Laveder; Giuseppe Faggian; Mauro Iafrancesco; Alessandro Mazzucco; Pier Franco Pignatti; Gerolamo Lanfranchi
Journal:  BMC Genomics       Date:  2009-01-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.